Search Thermo Fisher Scientific
A suggested positive control is human liver tissue lysate.
PA5-20922 can be used with blocking peptide PEP-1036.
LYRM3, also known as NADH dehydrogenase (ubiquinone) 1 beta subcomplex 9 (NDUFB9), is a ubiquitously expressed LYR-motif containing protein. It has been suggested to be a candidate gene for the branchio-oto-renal (BOR) syndrome, which is characterized by branchial and renal abnormalities and heredity deafness disorders. Other than its LYR-motif, LYRM3 appears to have no functional or structural relationship to either LYRM1 or LYRM2.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: CI-B22; complex I B22 subunit; Complex I-B22; LYR motif-containing protein 3; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa; NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9; NADH-ubiquinone oxidoreductase B22 subunit
基因别名: 1190008J14Rik; B22; CI-B22; LYRM3; NDUFB9; UQOR22
UniProt ID: (Human) Q9Y6M9, (Mouse) Q9CQJ8
Entrez Gene ID: (Human) 4715, (Mouse) 66218, (Rat) 299954